Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care — Stella

Recruiting

Back to Postpartum Period trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Israel

Holy family hospital, Nazareth, North

Key details

Sponsor

Holy Family Hospital, Nazareth, Israel

Enrollment target

~276 participants

Started

May 2025

Primary completion

May 2026

Age range

18 Years – 50 Years

Sex

Female only

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov